Vanderbilt-Ingram Cancer Center Archive — Page 6 of 27

Vanderbilt-Ingram website >

November 11, 2024

Southern Environmental Health Study recruiting participants 

People who sign up can help researchers assess whether environmental factors may be the culprits behind the region’s higher cancer burden.

By Tom Wilemon
(iStock)
November 4, 2024

Tae Kon Kim receives V Foundation grant for MDS drug research 

Kim and colleagues will study whether this protein hinders the ability of the immune system to fight MDS and whether it can be blocked to treat MDS.

By Tom Wilemon
October 31, 2024

Chic Awearness surpasses $1 million for ovarian cancer research and patient support 

Founded by Marci Houff, the event supports ovarian cancer research at Vanderbilt-Ingram Cancer Center and patient support initiatives.

By Tom Wilemon and Erin O. Smith
Michael Gibson, MD, PhD
October 30, 2024

Michael Gibson votes with FDA panel to limit immunotherapy indication 

The panel determined that allowing the wider indication would put patients at risk for adverse reactions from the two immunotherapies but without the added benefit in survival. 

By Tom Wilemon
Cathy Eng, MD
October 15, 2024

Cathy Eng named Vanderbilt-Ingram Cancer Center associate director of Strategic Relations and Research Partnerships 

Her new responsibilities will include promoting clinical research by developing new strategic partnerships with pharmaceutical and biotech companies.

By Tom Wilemon
color-enhanced cross section of tumor tissue
October 7, 2024

New Video: Study shows cancer vaccine blocks tumor progression at early lesion stage

Senior author Mary Philip, MD, PhD, associate director of the Vanderbilt Institute for Infection, Immunology and Inflammation, talks about her Journal for ImmunoTherapy of Cancer study.
The findings support further vaccine investigation to make long-term, progression-free survival a reality for more cancer patients.

By Tom Wilemon